Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Cancer Treat Res ; 101: 369-75, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10800657

RESUMO

The overall goal of adoptive immunotherapy with genetically modified lymphocytes is to decrease the morbidity and mortality associated with allogeneic bone marrow transplantation. The initial data reviewed here suggest that the behavior of the allogeneic HStk transgenic cells can be modified after administration to patients. Further study is needed to identify the response rates and risks associated with this procedure. In particular, larger studies will be needed with appropriate randomization to determine if the response rate to genetically modified cells is equivalent to the response rates with unmodified cells. Wider application of these techniques in the initial setting of allogeneic transplantation will undoubtedly occur and such trials have been initiated at several institutions. Careful attention to vector, suicide gene, selectable marker, efficiency of transduction, and cell dose will be necessary when comparing different trials since these variables will probably affect transgenic cell survival and response rates. [figure: see text]


Assuntos
Transfusão de Sangue Autóloga , Ganciclovir/uso terapêutico , Terapia Genética , Leucemia/terapia , Transfusão de Linfócitos , Simplexvirus/genética , Timidina Quinase/genética , Transplante de Medula Óssea/efeitos adversos , Efeito Enxerto vs Leucemia , Humanos , Imunoterapia Adotiva , Transplante Homólogo
2.
Am J Hematol ; 46(1): 43-7, 1994 May.
Artigo em Inglês | MEDLINE | ID: mdl-7514356

RESUMO

Twenty one patients with sickle cell disease admitted to the hospital with the pain of vaso-occlusive crisis (VOC) were treated by continuous IV infusion of ketorolac or normal saline for up to 5 days. All patients received supplemental IM injections of meperidine, 100 mg, as necessary, but not more frequently than every 3 hr. Over the 5 days the ketorolac treated patients (KT) required 33% less meperidine than did the placebo treated patients (PL), P = 0.04, and had significantly better pain relief as assessed by categorical, visual analog, and pain relief scales. By the end of 5 days infusions had been discontinued in six KT and one PL. The time to discontinuation of the infusion was significantly shorter in KT, (P = 0.009). The median duration of hospital stay from the start of treatment was 3.3 days for KT and 7.2 days for PL, P = 0.027. Adverse events were mainly related to the digestive system. This study showed that continuous infusion of ketorolac significantly reduced total meperidine requirement and that the analgesia produced by this combination was superior to that produced by meperidine alone. Further evaluation of this drug in the management of sickle cell VOC is warranted.


Assuntos
Anemia Falciforme/complicações , Cuidados Paliativos , Tolmetino/análogos & derivados , Trometamina/uso terapêutico , Doenças Vasculares/tratamento farmacológico , Doenças Vasculares/etiologia , Adulto , Analgésicos/uso terapêutico , Constrição Patológica/tratamento farmacológico , Constrição Patológica/etiologia , Doenças do Sistema Digestório/induzido quimicamente , Método Duplo-Cego , Combinação de Medicamentos , Estudos de Avaliação como Assunto , Feminino , Humanos , Cetorolaco de Trometamina , Masculino , Meperidina/uso terapêutico , Medição da Dor , Placebos , Tolmetino/efeitos adversos , Tolmetino/uso terapêutico , Trometamina/efeitos adversos
3.
J Nucl Med ; 27(5): 634-6, 1986 May.
Artigo em Inglês | MEDLINE | ID: mdl-3712080

RESUMO

The use of high dose 131I for workup of thyroid cancer patients increases the chance of contamination artifact which may mimic metastases. Two elderly male patients with follicular carcinoma of the thyroid had salivary contamination artifacts on metastatic survey scans. These patients received a 1 and 10 mCi dose of 131I, respectively. The artifacts were recognized only retrospectively when follow-up scans were obtained and compared. The characteristics of contamination artifacts and several methods to confirm these are discussed.


Assuntos
Radioisótopos do Iodo , Saliva/análise , Neoplasias da Glândula Tireoide/diagnóstico por imagem , Idoso , Reações Falso-Positivas , Humanos , Radioisótopos do Iodo/uso terapêutico , Masculino , Pessoa de Meia-Idade , Cintilografia , Ombro , Neoplasias Torácicas/secundário , Neoplasias da Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/radioterapia
4.
Am J Surg ; 148(6): 736-41, 1984 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-6334450

RESUMO

Lasers have been used for endoscopic gastrointestinal surgery at our institution since 1977. The argon and Nd-YAG lasers are valuable for coagulating upper gastrointestinal hemorrhage, arteriovenous malformations, and benign and malignant lesions, as well as a variety of anatomic anomalies. Between December 1977 and September 1983, 222 procedures were performed in 122 patients. Hospital charts were reviewed and a scale constructed to assess the results of treatment. When information was available, a comparison of transfusion requirements before and after laser therapy was made. Success was achieved in 84 percent of the patients regardless of initial diagnosis. Laser therapy was not effective in 12 patients (10 percent). In 27 patients with gastrointestinal atrioventricular malformations, transfusion requirements fell from a mean of 17 +/- 5.9 units in the year before laser therapy to 1 +/- 0.8 units in the year after laser phototherapy (p less than 0.01). Complications rarely occurred (6 percent of all procedures). There were no perforations of the gastrointestinal tract and only one death (0.8 percent) partially attributable to laser application. Endoscopic laser surgery is minimally invasive and can be performed on an outpatient basis without anesthesia. It is especially valuable in patients with a high operative risk.


Assuntos
Gastroenteropatias/cirurgia , Terapia a Laser , Adulto , Idoso , Malformações Arteriovenosas/cirurgia , Transfusão de Sangue , Procedimentos Cirúrgicos do Sistema Digestório , Endoscopia , Feminino , Hemorragia Gastrointestinal/cirurgia , Neoplasias Gastrointestinais/cirurgia , Humanos , Mucosa Intestinal/cirurgia , Masculino , Pessoa de Meia-Idade
5.
Hum Nutr Appl Nutr ; 37(5): 373-7, 1983 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-6668223

RESUMO

The amounts of some 40 fatty acids in British foods, derived from food tables and from a major new analytical survey, have been applied to National Food Survey results to give the average intake of each fatty acid in 1981. The major sources of the more significant fatty acids are also discussed.


Assuntos
Inquéritos sobre Dietas , Gorduras na Dieta/administração & dosagem , Ácidos Graxos/administração & dosagem , Análise de Alimentos , Inquéritos Nutricionais , Ácidos Graxos/análise , Ácidos Graxos Insaturados/administração & dosagem , Ácidos Graxos Insaturados/análise , Humanos , Programas Nacionais de Saúde , Reino Unido
6.
Neuroradiology ; 21(4): 199-205, 1981.
Artigo em Inglês | MEDLINE | ID: mdl-7254516

RESUMO

A retrospective study was made of 111 patients who underwent computed tomography (CT) and nuclear brain scans, with both pertechnetate and phosphate bone agents (PHOS), within 7 days of each other. Specifically, 78 patients who had a recent cerebral vascular accident (CVA) were compared. There were no significant sensitivity differences between the methods. While these studies appear complementary, the most important criterion is the time after onset when the studies were performed. The axiom "if the intensity of the phosphate scan exceeds that of the pertechnetate, the lesion must be a CVA" is true, only if the study is performed within 4 weeks of onset. The most economical method for optimum detection of CVA, with avoidance of frequent errors, is an early CT followed by a PHOS brain scan about 14 days after ictus in those that have initial negative CT.


Assuntos
Transtornos Cerebrovasculares/diagnóstico por imagem , Fosfatos , Tecnécio , Tomografia Computadorizada por Raios X , Adulto , Idoso , Humanos , Masculino , Pessoa de Meia-Idade , Cintilografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA